Individual bioequivalence—a european perspective

DOI10.1080/10543409708835166zbMATH Open0925.62482OpenAlexW1993337380WikidataQ41369480 ScholiaQ41369480MaRDI QIDQ4239494FDOQ4239494

Authors Volker W. Steinijans, Dieter Hauschke 

Publication date 20 June 1999

Published in Journal of Biopharmaceutical Statistics (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1080/10543409708835166

zbMATH Keywords

average bioequivalenceindividual bioequivalencepopulation bioequivalencesubject-by-formulation interactionequivalence acceptance limitshighly variable drugsreplicate designsscaled criteria

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• Assessment of Individual and Population Bioequivalence Using the Probability That Bioavailabilities are Similar
• Exact Inference About the Within-Subject Variability in 2 × 2 Crossover Trials
• The Subject-by-Formulation Interaction as a Criterion of Interchangeability of Drugs

This page was built for publication: Individual bioequivalence—a european perspective

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4239494)